
    
      Study Objective:

      â€¢To evaluate the safety and preliminary efficacy of ACZONE in subjects with papulopustular
      rosacea

      Study Population: Approximately 400 male and female subjects will be enrolled at 27 study
      centers in the United States.

      Study Treatment: Subjects will be randomized to 1 of 5 treatment regimens. Subjects will
      receive study medication for 12 weeks. Study participation is 13 weeks (5 clinic visits and 1
      telephone follow-up).
    
  